Updated:
Diamond BioFund
Diamond BioFund is Taiwan's first listed sustainable biotechnology venture capital firm. Founding shareholders include 中天生技, 富邦金控, 台新金控 and 潤泰集團.
Diamond BioFund
Diamond BioFund is Taiwan's first listed sustainable biotechnology venture capital firm. Founding shareholders include 中天生技, 富邦金控, 台新金控 and 潤泰集團. The firm focuses on biotech and healthcare investments—including new drug R&D, advanced medical devices, innovative medical services, medical channels and agricultural biotech—and has invested in and incubated more than 20 biotech startups in Taiwan and abroad. It assists portfolio companies on governance, R&D, clinical execution, commercial development and capital-market access to accelerate value creation for shareholders.
General information
Firm type
Private Equity
Year founded
2013
Location
Region
Asia
Country
Taiwan
City
Taipei City
Corporate office
Taipei City, Taiwan
Principals
李祖德，副董事長
Sector focus
Frequently asked questions
Who runs investment decisions at Diamond BioFund?
No named principals or investment committee members are disclosed in public sources.
What investment stages does Diamond BioFund typically target?
The firm targets balanced, early-stage seed, start-up, growth, succession, and general venture opportunities.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: